AB 16. Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer

BACKGROUND: To evaluate the effect of immunotherapy on response, survival and certain immunologic markers in SCLC patients receiving chemotherapy. PATIENTS AND METHODS: A total of 191 SCLC patients assigned to receive either chemotherapy alone (group A) or combination of chemotherapy and immunothera...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zarogoulidis, Konstantinos, Ziogas, Eleftherios, Boutsikou, Efthimia, Zarogoulidis, Paul, Porpodis, Konstantinos, Latsios, Dimitris, Eleftheriadou, Ellada, Xatzizisi, Ourania, Kiriazis, Georgios
Format: Artigo
Idioma:Inglês
Publicat: Pioneer Bioscience Publishing Company 2012
Matèries:
Abstract
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3537413/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2012.s016
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars